Cellectis SA CMVLF:OTCPK

RT Quote | Exchange | USD
Last | 05/11/22 EDT
2.97UNCH (UNCH)
52 week range
2.97 - 16.05
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.97
  • 52 Week High16.05
  • 52 Week High Date07/01/21
  • 52 Week Low2.97
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap140.91M
  • Shares Out45.48M
  • 10 Day Average Volume712
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-63.38

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.97
  • 52 Week High16.05
  • 52 Week High Date07/01/21
  • 52 Week Low2.97
  • 52 Week Low Date05/11/22
  • Market Cap140.91M
  • Shares Out45.48M
  • 10 Day Average Volume712
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-63.38

RATIOS/PROFITABILITY

  • EPS (TTM)-2.97
  • P/E (TTM)-1.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cellectis SA

There is no recent news for this security.

Profile

MORE
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease...
Jean-Pierre Garnier Ph.D.
Non-Executive Independent Chairman of the Board
Andre Choulika Ph.D.
Director, Chief Executive Officer and Co-Founder, Member of the Executive Board
Bing Wang Ph.D.
Chief Financial Officer, Member of the Executive Board
Marie-Bleuenn Terrier
General Counsel, Member of the Executive Committee
Address
8, rue de la Croix Jarry
Paris
75013
France